• Chris Fox Novartis Gene Therapies
    Image attribution tooltip
    Permission granted by Chris Fox Novartis Gene Therapies

    Woman of the Week: Novartis Gene Therapies’ Chris Fox

    Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. When Novartis acquired AveXis and its spinal muscular atroph...

    By March 15, 2023
  • Senior older women
    Image attribution tooltip
    Stock via Getty Images

    Targeting the new ‘Golden Girls’

    With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.

    By March 8, 2023
  • drug injection cost
    Image attribution tooltip
    Stock via Getty Images

    Multimillion-dollar therapies are changing how payers foot the bill

    With more gene therapies headed to market, novel payment methods are emerging from regulators and academia. 

    By Feb. 28, 2023
  • patient care
    Image attribution tooltip
    Stock via Getty Images

    Why patient care is a public affair

    The VP of public affairs at Kyowa Kirin discusses her role in advocating for advocacy.

    By Feb. 23, 2023
  • Ester Banque Bristol Myers Squibb
    Image attribution tooltip
    Permission granted by Ester Banque Bristol Myers Squibb

    Woman of the Week: Bristol Myers Squibb’s Ester Banque

    The 30-year veteran is heading up the “transformation” of one of the pharma giant’s most important therapeutic portfolios: hematology.

    By Feb. 15, 2023
  • Multicolored wave lines in the shape of an eye
    Image attribution tooltip
    Stock via Getty Images

    For Complement’s CEO, storytelling could be just as critical as data

    Dr. Rafiq Hasan has his sights on bringing lessons learned at Bayer to ophthalmology-focused Complement Therapeutics.

    By Alexandra Pecci • Feb. 14, 2023
  • Professional headshot of Brian Fox
    Image attribution tooltip
    Permission granted by Klick Group
    Q&A // First 90 Days

    Brian Fox is bringing ‘fresh eyes’ to ad agency Klick

    Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

    By Feb. 13, 2023
  • Doctor sits at her office and using mobile smart phone
    Image attribution tooltip


    Sponsored by LiveWorld

    Survey results: Social influences HCP perceptions and prescriptions

    Build social strategies into marketing plans to reach HCPs with sharply focused messaging.

    Feb. 13, 2023
  • The Federal Trade Commission headquarters is pictured in Washington, D.C. The agency's proposed noncompete ban may face legal challenges on several grounds.
    Image attribution tooltip
    RiverNorthPhotography via Getty Images

    Antitrust watchdogs have pharma in their sights, and the landscape is getting thornier

    The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target.

    By Feb. 2, 2023
  • Yesmean Wahdan Bayer
    Image attribution tooltip
    Permission granted by Yesmean Wahdan Bayer

    Woman of the Week: Bayer’s Dr. Yesmean Wahdan

    The VP of medical affairs and women’s health is focused on an audacious goal to meet the needs of 100 million women globally.

    By Feb. 1, 2023
  • booster
    Image attribution tooltip
    Stock via Getty Images

    Vaxxinity eyes global COVID-19 vaccine market with ‘next-gen’ booster

    The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.

    By Alexandra Pecci • Jan. 31, 2023
  • Teens in circle holding smart mobile phones of different colors.
    Image attribution tooltip
    Stock via Getty Images

    Patients are using social media — clinical trial experts can learn from that

    Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights. 

    By Jan. 30, 2023
  • scale
    Image attribution tooltip
    Stock via Getty Images

    Weight loss drugs: the promise and pitfalls

    GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.

    By Kelly Bilodeau • Jan. 30, 2023
  • Woman relaxing on sofa, enjoying web surfing information in internet
    Image attribution tooltip


    Sponsored by LiveWorld

    Boost returns from social strategies with new channels and tactics

    Emerging channels offer new ways to reach key targets and improve campaign ROI.

    Jan. 30, 2023
  • A brown building with white vertical sign with the Twitter logo
    Image attribution tooltip
    Justin Sullivan/Staff via Getty Images

    With Twitter in flux, pharma is turning to alternative social spaces

    Elon Musk’s takeover of Twitter has upended the ways pharma companies communicate with doctors online. Now new social strategies are emerging.

    By Jan. 26, 2023
  • Johanna Mercier headshot
    Image attribution tooltip
    Permission granted by Gilead Sciences

    Gilead’s commercial chief on why 2023 will be a ‘coming out’ year

    With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses Gilead’s quest to transform.

    By Jan. 26, 2023
  • Lauren Lazar Calcium
    Image attribution tooltip
    Permission granted by Lauren Lazar Calcium

    Woman of the Week: Dr. Lauren Lazar

    As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

    By Jan. 25, 2023
  • 3D Illustration Concept of Human Respiratory System Lungs Anatomy
    Image attribution tooltip
    magicmine, iStock / Getty Images Plus via Getty Images

    AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships

    A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra.

    By Jan. 24, 2023
  • A prescription bottle with white pills and a wooden gavel sit atop a $100 bill showing Benjamin Franklin's face.
    Image attribution tooltip
    Bill Oxford via Getty Images

    Drug price negotiations: 5 key dates to watch

    As the CMS readies its new program for lowering drug costs, these are the moments that will matter most to pharma companies.

    By Kelly Bilodeau • Jan. 23, 2023
  • Astellas' U.S. headquarters in Northbrook, IL.
    Image attribution tooltip
    Permission granted by Astellas

    Already on a roll in oncology, Astellas hunts for big wins in other areas

    With two potential first-in-class drug launches on the horizon, and a budding gene therapy business, Astellas believes this year could be a major inflection point. 

    By Jan. 23, 2023
  • Doctor in clinic
    Image attribution tooltip

    Jacob Lund/

    Sponsored by LiveWorld

    Tactics for growing your walled garden presence

    Cultivate relationships with HCPs in gated social platforms with content that will thrive.

    Jan. 23, 2023
  • The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
    Image attribution tooltip
    Sarah Silbiger/Getty Images via Getty Images

    FDA’s 2022 drug approvals fall short of recent norms

    The U.S. agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval.

    By Alexandra Pecci • Jan. 19, 2023
  • Novavax vaccine
    Image attribution tooltip
    Carsten Koall via Getty Images

    After ‘limping along,’ Novavax sees a path forward

    With a new CEO and a long-term booster strategy, the company believes there’s plenty of room to grow in the COVID-19 vaccine space.

    By Jan. 18, 2023
  • Twitter headquarters stands on 10th Street on November 4, 2022 in San Francisco, California.
    Image attribution tooltip
    David Odisho via Getty Images

    Can pharma quit Twitter? Social strategy evolves as Musk changes the platform

    A breakdown of how Twitter’s recent shifts are impacting pharma, and how the industry should navigate the platform in 2023.

    By Dec. 16, 2022
  • Vicki Goodwin Exelexis
    Image attribution tooltip
    Permission granted by Exelexis’ Dr. Vicki Goodman

    Woman of the Week: Exelixis’ Dr. Vicki Goodman

    With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.

    By Dec. 14, 2022